Drug Shortage Report for JAMP CANDESARTAN-HCT

Last updated on 2021-12-21 History
Report ID 149818
Drug Identification Number 02473259
Brand name JAMP CANDESARTAN-HCT
Common or Proper name Candesartan Cilexetil and Hydrochlorothiazide Tablets
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL
Strength(s) 12.5MG 32MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-05
Estimated end date 2021-12-03
Actual end date 2021-12-17
Shortage status Resolved
Updated date 2021-12-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-11-24 English Compare
v2 2021-11-24 French Compare
v3 2021-12-21 English Compare
v4 2021-12-21 French Compare

Showing 1 to 4 of 4